CClinicalTrials.gg
CompletedNCT04213144Updated Apr 4, 2023

Evaluate the Influence of Electromagnetic Field as an Adjunctive Non Surgical Treatment in Implant With Peri-implantitis

An interventional study of Magdent Cap MED and Sham MED in Peri-Implantitis, sponsored by Rambam Health Care Campus. Completed at 1 site in Israel. Open to participants aged 20 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-04.

Sponsored by Rambam Health Care Campus · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
20 Years to 85 Years
Sex
All
01

Study summary

the aim of the study is to compare between two non-surgical methods of treatment of peri-implantitis by using debridement and placing an healing abutment with electomagnetic field (MED-Magdent Miniaturized Device) in the test group and Sham healing abutment in the control group ( Sham MED).

Read the detailed description

Dental Implants are common alternative for replacement at the time of tooth loss. The two common methods for treatment implant with inflammation include surgical and global non-surgical treatment.

The non-surgical treatment includes soft tissue debridement with various tools which including manual, ultrasonic rotators, lasers and delayed release devices.

Using an electromagnetic field to induce bony healing in fractures and around implants is being investigated for studies and was found to be effective and safe. The electric field lowers osteoclasts activity, speeds up osteoid construction and stimulates creation blood vessels development. Forty patients who will attend to the department of periodontology at Rambam health care campus, at the School ofpostgraduate Dentistry, which will meet the research criteria, will be recruited. All patients will exhibit a moderate-onset gum infection around one of the implants.

02

Conditions studied

  • Peri-Implantitis

Browse trials for

03

In context

Peri-Implantitis

304 studies on the registry are indexed under Peri-Implantitis; 84 are open to participants now.

This study's enrollment of 23 is below the median of 40 across 182 interventional studies indexed under Peri-Implantitis.

Browse Peri-Implantitis studies →

Lead sponsor

Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Written informed consent.
  • Patients of 20 - 85 years.
  • pocket depth of 5-8 mm and bone loss of 3-5mm Patients with fixed prosthodontics Implant with standart width

Exclusion criteria

Exclusion Criteria:

  • Heavy smokers (more than 10 cigarettes per day).
  • Pregnant women
  • active periodontal disease
  • Consumption of Non Steroidal Anti Inflammatory drugs
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Magdent Cap MED

    Soft and hard tissue healing with electomagnetic healing abutment.

    Device: Magdent Cap MED

  • Sham comparator
    Sham MED

    Soft and hard tissue healing with a regular healing abutment.

    Device: Sham MED

Interventions

  • DeviceMagdent Cap MED

    Magdent is intended to be used for accelaration of soft tissue and bone healing

  • DeviceSham MED

    Sham MED is intended to be used for soft tissue healing

06

What researchers measure

Primary outcomes

  1. Change in the implant probing depth (IPD)

    clinical measurement of the depth of the pocket around the implant in 6 sites

    Time frame: baseline, 4 weeks, 12 weeks

Secondary outcomes

  1. changing in the concentration of the RANKL cytokine

    Sampling the amount bycollecting gingival fluid with paper pins and examining the amount of the cytokine with ELISA (Enzyme Linked Immunoflorecance assay)asay

    Time frame: baseline, 2 weeks, 4 weeks, 12 weeks

07

Study locations

1 site
  • Rambam Health Care Campus, Dept. of Periodontology
    Haifa, 31096, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04213144
Lead sponsor
Rambam Health Care Campus
Responsible party
Hadar Zigdon MD (Rambam Health Care Campus, Rambam Health Care Campus) — Principal investigator
First posted
Dec 30, 2019
Start date
Mar 3, 2020
Primary completion
Oct 19, 2022
Completion
Oct 19, 2022
Last update
Apr 4, 2023

Study contacts

Hadar Zigdon, DMD
principal investigator · Rambam Health Care Campus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion